 The purpose of this study is to evaluate the effectiveness and safety of trabectedin in 3 subpopulations of participants with previously treated progressive metastatic spread of a cancer from one organ or part to another non-adjacent organ or part breast cancer abnormal tissue that grows and spreads in the body until it kills participants. 